From Patient Partnership to Pharma Impact
In an industry where more and more studies face delays and fewer than half of clinical trials achieve full enrolment, two forces are converging to reshape clinical development: artificial intelligence and authentic patient partnership. Together, they offer a powerful solution to long-standing challenges in recruitment, retention, and trial efficiency—while also addressing the growing threat of misinformation.
Download this white paper to discover how to transform healthcare through AI and cross-collaboration >>>  
Commentary and analysis by leading pharma experts:
  • Amy Akers Teets. Global Head Patient Strategy, Specialty Care, Sanofi
  • Tom Croce, VP, Patient Advocacy, Jazz Pharmaceuticals
  • Katie Sugarman, SVP, Clinical Development Strategy, Genmab
  • Daniel McNamara, Head of Patient Services, North America, Kyowa Kirin
  • Nirmit Kumar, Senior Global Medical Affairs Leader, Breast Cancer Dx, AstraZeneca
Don’t get left behind, read our latest expert analysis to elevate your own AI strategy  >>>  
We hope you enjoy!

Kindest regards,
Download your white paper here

With analysis and case studies from senior leaders at AstraZeneca, Sanofi and Genmab.
I consent to Thomson Reuters using the personal information provided above to send me marketing communications about its products and services. I understand I can opt-out at any time.
Reuters Events is part of Reuters News & Media Ltd, 5 Canada Square, Canary Wharf, London, E14 5AQ. Registered in England and Wales: 2505735.